Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

Charting, Price Performance, News & Related Contracts.

Charting, Price Performance, News & Related Contracts.

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today presented new global, real-world, patient-centric data, including data from a study assessing the impacts on quality of life ...

Read ahead to know about what a cardiac shunt is its types symptoms causes and treatment options An expert shares when to ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...

AllRock Bio, Inc., a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary and fibrotic diseases, today announced the dosing of the first patients in the ...

Every so often, doctors run into a condition so rare that it has them puzzled. With its non-specific symptoms, PVOD is one of ...

Scientists have created a new "molecular map" uncovering how an important human receptor involved in blood clotting and ...

A University of Alberta research team has found a genetic variant that can be used to identify which patients with pulmonary arterial hypertension need the most urgent care. "This could potentially ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), announced today that ...

A University of Alberta research team has found a genetic variant that can be used to identify which patients with pulmonary arterial hypertension ...